Abstract — The aim of this study is to identify a gene signature which is characteristic of ER status in breast cancer patients. To our knowledge, this is the first microarray study in Greece concerning breast cancer. We identified 97 genes that are characteristic for ER status and can well distinguish the ER+ from the ER- samples. We also managed to shrink our list to a 11-gene list giving the same prognostic outcome. We found a significant overlap of these genes with published prognostic signatures like the ones of West et.al. [4] and of Van’t Veer et. al. [1]. This fact is very encouraging given the minimal overlap of such genes reported by others [28]. In order to give a meaningful information to the doctors we found associations with b...
Previous transcriptome-wide association studies (TWAS) have identified breast cancer risk genes by i...
The occurrence of large publically available repositories of human breast tumor gene expression prof...
Background Molecular markers have transformed our understanding of the heterogeneity of breast ca...
Estrogen signaling plays an essential role in breast cancer progression, and estrogen receptor (ER) ...
Estrogen signaling plays an essential role in breast cancer progression, and estrogen receptor (ER) ...
Gene-expression profiling with the use of DNA microarrays al-lows measurement of thousands of messen...
Abstract Background Estrogens are known to regulate the proliferation of breast cancer cells and to ...
Breast cancer is the most common cancer in women worldwide. Most breast cancers are hormone related ...
Comprehensive gene expression patterns generated from cDNA microarrays were correlated with detailed...
Most metastatic breast cancers arise from estrogen receptor α (ER)-positive disease, and yet the rol...
The objective of the present study was to validate prognostic gene signature for estrogen receptor a...
AbstractGene signatures have been developed for estrogen receptor-positive breast cancer to compleme...
Previous transcriptome-wide association studies (TWAS) have identified breast cancer risk genes by i...
Breast cancers fall into two major classes depending on their estrogen receptor (ER) status. ER+ and...
Abstract Background Breast cancer is a heterogeneous disease and personalized medicine is the hope f...
Previous transcriptome-wide association studies (TWAS) have identified breast cancer risk genes by i...
The occurrence of large publically available repositories of human breast tumor gene expression prof...
Background Molecular markers have transformed our understanding of the heterogeneity of breast ca...
Estrogen signaling plays an essential role in breast cancer progression, and estrogen receptor (ER) ...
Estrogen signaling plays an essential role in breast cancer progression, and estrogen receptor (ER) ...
Gene-expression profiling with the use of DNA microarrays al-lows measurement of thousands of messen...
Abstract Background Estrogens are known to regulate the proliferation of breast cancer cells and to ...
Breast cancer is the most common cancer in women worldwide. Most breast cancers are hormone related ...
Comprehensive gene expression patterns generated from cDNA microarrays were correlated with detailed...
Most metastatic breast cancers arise from estrogen receptor α (ER)-positive disease, and yet the rol...
The objective of the present study was to validate prognostic gene signature for estrogen receptor a...
AbstractGene signatures have been developed for estrogen receptor-positive breast cancer to compleme...
Previous transcriptome-wide association studies (TWAS) have identified breast cancer risk genes by i...
Breast cancers fall into two major classes depending on their estrogen receptor (ER) status. ER+ and...
Abstract Background Breast cancer is a heterogeneous disease and personalized medicine is the hope f...
Previous transcriptome-wide association studies (TWAS) have identified breast cancer risk genes by i...
The occurrence of large publically available repositories of human breast tumor gene expression prof...
Background Molecular markers have transformed our understanding of the heterogeneity of breast ca...